Why the study?
To clarify the current approach of care in pediatric patients with familial hypercholesterolemia and address whether advances in lipid management apply to children and adolescents.
Early detection and intensive lipid-lowering treatment in children and adolescents with familial hypercholesterolemia are crucial to prevent premature atherosclerotic cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Supports intensified lipid management in pediatric FH; leaves open optimal timing, intensity, and long-term safety.
Cohen et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: